Blue Crest Capital Management LTD Gilead Sciences, Inc. Transaction History
Blue Crest Capital Management LTD
- $2.09 Billion
- Q2 2025
A detailed history of Blue Crest Capital Management LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Blue Crest Capital Management LTD holds 13,553 shares of GILD stock, worth $1.63 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
13,553Holding current value
$1.63 Million% of portfolio
0.07%Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
2,342Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.13 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.58 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.52 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $151B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...